These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6131432

  • 1. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF, Sharpless NE, Goosey JD.
    Prog Clin Biol Res; 1982; 114():243-59. PubMed ID: 6131432
    [No Abstract] [Full Text] [Related]

  • 2. Irreversible aldose reductase inhibitors.
    Kador PF, Gurley RC, Ares JJ, Miller DD.
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract] [Full Text] [Related]

  • 3. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF, Kinoshita JH, Tung WH, Chylack LT.
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [Abstract] [Full Text] [Related]

  • 4. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF, Sharpless NE.
    Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of lens-aldose reductase activity by brazilin and haematoxylin.
    Moon CK, Yun YP, Lee JH, Wagner H, Shin YS.
    Planta Med; 1985 Feb; (1):66-7. PubMed ID: 3925476
    [No Abstract] [Full Text] [Related]

  • 6. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ, Shen ZF.
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of lens aldose reductase by Labiatae flavonoids.
    Tomás-Barberán FA, López-Gómez C, Villar A, Tomás-Lorente F.
    Planta Med; 1986 Jun; (3):239-40. PubMed ID: 3092256
    [No Abstract] [Full Text] [Related]

  • 8. Ponalrestat: a potent and selective inhibitor of bovine lens aldose reductase.
    Tuffin DP, Dingle A, Sennitt CM, Mirrlees DJ, Ward WH.
    Prog Clin Biol Res; 1989 Jun; 290():221-35. PubMed ID: 2498899
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of aldose reductase activities by kampo medicines.
    Aida K, Shindo H, Tawata M, Onaya T.
    Planta Med; 1987 Apr; 53(2):131-5. PubMed ID: 3110810
    [No Abstract] [Full Text] [Related]

  • 10. Placental aldose reductase inhibition by Silybin (preliminary communication).
    Santos J, Mira LB, Freire AM, Azevedo M, Manso C.
    Acta Med Port; 1984 Apr; 5(4-5):115-7. PubMed ID: 6431756
    [No Abstract] [Full Text] [Related]

  • 11. What is the nature of the charge transfer interaction at the aldose reductase inhibitor site.
    Kador PF, Nakayama T, Sato S, Smar M, Miller DD.
    Prog Clin Biol Res; 1989 Apr; 290():237-50. PubMed ID: 2498900
    [No Abstract] [Full Text] [Related]

  • 12. Aldose reductases from human retina and bovine lens: dependence of inhibition upon the choice of enzyme substrate.
    Poulsom R.
    Prog Clin Biol Res; 1987 Apr; 232():341-52. PubMed ID: 3112787
    [No Abstract] [Full Text] [Related]

  • 13. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
    Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P.
    Mol Pharmacol; 1984 May; 25(3):425-30. PubMed ID: 6427599
    [Abstract] [Full Text] [Related]

  • 14. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Hatanaka I, Shigeta Y.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.
    Pfister JR, Wymann WE, Mahoney JM, Waterbury LD.
    J Med Chem; 1980 Nov; 23(11):1264-7. PubMed ID: 6779009
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of aldose reductase by 3',4'-dihydroxyflavones.
    Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M.
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):767-72. PubMed ID: 6428761
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications.
    Varma SD.
    Prog Clin Biol Res; 1986 Feb; 213():343-58. PubMed ID: 3086893
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of aldose reductase in human cataractous lens and placenta].
    Yoshida H, Miyata M.
    Nippon Ganka Gakkai Zasshi; 1982 Feb; 86(9):1370-8. PubMed ID: 6818855
    [No Abstract] [Full Text] [Related]

  • 19. Isoxazolidine-3,5-diones as lens aldose reductase inhibitors.
    Richon AB, Maragoudakis ME, Wasvary JS.
    J Med Chem; 1982 Jun; 25(6):745-7. PubMed ID: 6808134
    [No Abstract] [Full Text] [Related]

  • 20. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
    Kador PF, Sharpless NE.
    Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.